What is YGEN.L's Intrinsic value?

Yourgene Health PLC (YGEN.L) Intrinsic Value Analysis

Executive Summary

As of May 27, 2025, Yourgene Health PLC's estimated intrinsic value ranges from $0.00 to $0.00 per share, depending on the valuation methodology applied.

Valuation Method Fair Value (USD) Implied Upside/Downside

Is Yourgene Health PLC (YGEN.L) undervalued or overvalued?

With the current market price at $0.52, the stock appears to be significantly overvalued.

Understanding Intrinsic Value

Intrinsic value represents the "true" worth of a company based on its fundamentals rather than market sentiment. We've employed multiple methodologies to triangulate Yourgene Health PLC's intrinsic value, including:

Weighted Average Cost of Capital (WACC)

The cost of capital is a critical factor in valuation models, representing the required return for investors.

WACC Component Low High
Long-term bond rate 4.0% 4.5%
Equity market risk premium 6.0% 7.0%
Adjusted beta 0.31 0.4
Cost of equity 5.9% 7.8%
Cost of debt 7.0% 17.7%
Tax rate 1.1% 12.1%
Debt/Equity ratio 1.16 1.16
After-tax WACC 6.4% 11.9%

Valuation Methods

Key Financial Metrics

Metric Value
Market Capitalization $16M
Enterprise Value $32M
Trailing P/E 0.00
Forward P/E 0.00
Trailing EV/EBITDA 15.70
Current Dividend Yield 0.00%
Dividend Growth Rate (5Y) 0.00%
Debt-to-Equity Ratio 1.16

Investment Decision Framework

To determine the most reliable intrinsic value estimate, we weigh each valuation method based on:

  1. Forecast Certainty: DCF methods rely on long-term projections, while earnings power value focuses on current normalized earnings
  2. Business Model Alignment: Dividend models are more appropriate for mature companies with established dividend policies
  3. Historical Accuracy: How well each method has predicted fair value historically

Valuation Weight Matrix

Valuation Method Weight Weighted Value
Weighted Average 100% $0.00

Investment Conclusion

Based on our comprehensive valuation analysis, Yourgene Health PLC's weighted average intrinsic value is $0.00, which is approximately 100.0% below the current market price of $0.52.

Key investment considerations:

  • Strong projected earnings growth (-5% to 3% margin)
  • Consistent cash flow generation

Given these factors, we believe Yourgene Health PLC is currently significantly overvalued with the potential for long-term appreciation based on the company's growth trajectory and financial strength.